United Kingdom

Chugai Pharmaceutical Co Ltd (4519.T)

4519.T on Tokyo Stock Exchange

30 Sep 2016
Change (% chg)

¥-30 (-0.82%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4519.T


CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the Company through its nationwide appointed stores. This segment is also involved in the research, development, transportation and storage of pharmaceutical products, as... (more)


Beta: 0.70
Market Cap(Mil.): ¥2,051,249.00
Shares Outstanding(Mil.): 559.69
Dividend: 26.00
Yield (%): 1.42


  4519.T Industry Sector
P/E (TTM): 32.06 36.94 36.87
EPS (TTM): 114.33 -- --
ROI: 9.80 14.36 13.86
ROE: 10.08 15.19 14.81

BRIEF-Chugai and Galderma announce global license agreement for Nemolizumab

* Chugai will continue to be responsible for product manufacturing and supply of Nemolizumab.

21 Jul 2016

BRIEF-Chugai Pharmaceutical says concluded a license agreement with Roche

* Announced that it concluded a license agreement with roche for "sa237"

01 Jun 2016

BRIEF-Chugai Pharmaceutical announces results of Japanese phase III study of Alecensa

* Announced results of Japanese phase III study of Alecensa in Alk fusion gene positive non-small cell lung cancer

19 May 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : GlobalData
Provider : MarketLine

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.